Cardinal Health (CAH) to Release Quarterly Earnings on Thursday

Cardinal Health (NYSE:CAH) will post its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Cardinal Health to post earnings of $1.96 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, February 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The business had revenue of $57.45 billion during the quarter, compared to analysts’ expectations of $57.02 billion. During the same period in the prior year, the company earned $1.32 earnings per share. The firm’s revenue was up 11.6% on a year-over-year basis. On average, analysts expect Cardinal Health to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Cardinal Health Trading Up 0.2 %

Shares of CAH stock opened at $103.54 on Thursday. Cardinal Health has a 12 month low of $77.56 and a 12 month high of $116.04. The stock has a market cap of $25.18 billion, a P/E ratio of 40.76, a P/E/G ratio of 0.99 and a beta of 0.68. The company has a 50 day simple moving average of $109.56 and a two-hundred day simple moving average of $104.59.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were issued a dividend of $0.5006 per share. The ex-dividend date was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a yield of 1.93%. Cardinal Health’s dividend payout ratio is currently 78.74%.

Wall Street Analysts Forecast Growth

CAH has been the subject of a number of research reports. TheStreet cut shares of Cardinal Health from a “b-” rating to a “c+” rating in a report on Wednesday, December 27th. Leerink Partnrs reaffirmed an “outperform” rating on shares of Cardinal Health in a report on Monday, February 26th. StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday. Barclays initiated coverage on shares of Cardinal Health in a report on Wednesday, January 3rd. They set an “overweight” rating and a $117.00 target price for the company. Finally, Argus raised shares of Cardinal Health from a “hold” rating to a “buy” rating in a research note on Friday, February 9th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $103.07.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.